Cough and Cold Preparations Market in Greece to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Cough and Cold Preparations Market in Greece (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

• Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
• Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights

The cough and cold preparations category was valued at €90.3m ($132.2m) in 2009, representing a CAGR of 12.9% since 2004.

By the end of 2014, the cough and cold preparations category will be worth €146.5m ($214.6m), with an expected CAGR of 10.2% between 2009 and 2014.

The cough and cold preparations market was led by mixtures (representing 54.4% of the total value) followed by lozenges and tablets, with a 22.1% and 18.4% market share, respectively. Topical remedies and inhalers constitute the remaining segments with a 4.1% and 1% market share, respectively.

Apivita S.A. is the market leader with a 33.3% share of the market.

Reasons to Purchase

• Develop business strategies by understanding the quantitative trends within the Cough and Cold Preparations Market in Greece (OTC Healthcare)
• Design effective marketing and sales strategies by identifying key market categories and segments
• Identify key players within the market to plan lucrative M&A, partnerships and agreements